Collegium Pharmaceutical (COLL) Net Margin Growth (1y) (2017 - 2026)
Collegium Pharmaceutical (COLL) Net Margin Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Collegium Pharmaceutical | 892.02 Mn | 742.71 Mn | 110.29 Mn | -1,390.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12,296.00 |
| Mar 31, 2026 | 613.00 |
| Dec 31, 2025 | -2,541.00 |
| Sep 30, 2025 | 919.00 |
| Jun 30, 2025 | -712.00 |
| Mar 31, 2025 | -1,776.00 |
| Dec 31, 2024 | 1,233.00 |
| Sep 30, 2024 | -923.00 |
| Jun 30, 2024 | 390.00 |
| Mar 31, 2024 | 3,116.00 |
| Dec 31, 2023 | 2,645.00 |
| Sep 30, 2023 | 1,473.00 |
| Jun 30, 2023 | 1,380.00 |
| Mar 31, 2023 | 357.00 |
| Dec 31, 2022 | 6,020.00 |
| Sep 30, 2022 | -985.00 |
| Jun 30, 2022 | -9,343.00 |
| Mar 31, 2022 | -3,479.00 |
| Dec 31, 2021 | -7,444.00 |
| Sep 30, 2021 | -405.00 |